DrugPatentWatch Database Preview
Pfizer Ireland Company Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the competitive landscape for PFIZER IRELAND, and what generic and branded alternatives to PFIZER IRELAND drugs are available?
PFIZER IRELAND has one approved drug.
Summary for Pfizer Ireland
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
| Patent Litigation for Pfizer Ireland: | See patent lawsuits for Pfizer Ireland |
Drugs and US Patents for Pfizer Ireland
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer Ireland | RELPAX | eletriptan hydrobromide | TABLET;ORAL | 021016-001 | Dec 26, 2002 | AB | RX | Yes | No | Start Trial | Start Trial | ||||
| Pfizer Ireland | RELPAX | eletriptan hydrobromide | TABLET;ORAL | 021016-002 | Dec 26, 2002 | AB | RX | Yes | Yes | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Pfizer Ireland
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Pfizer Ireland | RELPAX | eletriptan hydrobromide | TABLET;ORAL | 021016-001 | Dec 26, 2002 | 5,545,644 | Start Trial |
| Pfizer Ireland | RELPAX | eletriptan hydrobromide | TABLET;ORAL | 021016-002 | Dec 26, 2002 | 6,110,940 | Start Trial |
| Pfizer Ireland | RELPAX | eletriptan hydrobromide | TABLET;ORAL | 021016-002 | Dec 26, 2002 | 5,545,644 | Start Trial |
| Pfizer Ireland | RELPAX | eletriptan hydrobromide | TABLET;ORAL | 021016-001 | Dec 26, 2002 | 6,110,940 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for PFIZER IRELAND drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Tablets | 20 mg and 40 mg | ➤ Subscribe | 2010-03-29 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
